The use of four-factor prothrombin complex concentrate in patients with liver disease on warfarin therapy

被引：2
|
作者：
Stevens, Craig A. [1 ]
Yau, Benny C. [2 ]
Lai, Ngan C. [3 ]
Huang, Wan-Ting [1 ]
Cang, William C. [1 ]
Bushway, Audrey [1 ]
Derry, Katrina L. [1 ]
机构：
[1] UC San Diego Hlth, Dept Pharm, San Diego, CA USA
[2] Stanford Hlth Care, Dept Pharm, Stanford, CA USA
[3] Sutter Hlth Care, Dept Pharm, Oakland, CA USA
来源：
THROMBOSIS RESEARCH | 2021年 / 204卷
关键词：
COAGULOPATHY; PROTECT;
D O I：
10.1016/j.thromres.2021.06.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [31] THREE-VERSUS FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR REVERSAL OF WARFARIN-INDUCED BLEEDING
    Holt, Tara
    Taylor, Scott
    Abraham, Prasad
    McMillian, Wesley
    Elder, Tai
    Harris, Serena
    Curtis, Jim
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [32] Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage
    Ryan M. Rivosecchi
    Joseph Durkin
    David O. Okonkwo
    Bradley J. Molyneaux
    Neurocritical Care, 2016, 25 : 359 - 364
  • [33] Clinical Outcomes of Patients Treated With Idarucizumab for Dabigatran Reversal versus Four-factor Prothrombin Complex Concentrate for Warfarin Reversal
    Clare, Ryan
    Hekimian, Avetis
    Rafie, Reza
    Kim, Cy
    Shen, Albert Y.
    Lee, Mingsum
    CIRCULATION, 2017, 136
  • [34] EVALUATION OF FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT WARFARIN REVERSAL IN PATIENTS WITH INTRACRANIAL HEMORRHAGE
    Scott, Rachael
    Kersten, Brian
    Basior, Jeanne
    Nadler, Megan
    JOURNAL OF EMERGENCY MEDICINE, 2018, 54 (06): : 861 - 865
  • [35] Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage
    Rivosecchi, Ryan M.
    Durkin, Joseph
    Okonkwo, David O.
    Molyneaux, Bradley J.
    NEUROCRITICAL CARE, 2016, 25 (03) : 359 - 364
  • [36] USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE VERSUS ACTIVATED FACTOR SEVEN IN CARDIAC SURGERY
    Audley, Kristen
    Rosini, Jamie
    Tully, Andrea
    Zizza, Laura
    CRITICAL CARE MEDICINE, 2019, 47
  • [37] USE OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR COAGULOPATHIC BLEEDING DURING CARDIAC SURGERY
    Maynard, Kaylee
    Falvey, Jennifer
    Groth, Christine
    CRITICAL CARE MEDICINE, 2020, 48
  • [38] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE IN ANTICOAGULATION-NAIVE CARDIOTHORACIC SURGERY PATIENTS
    Bundy, Angela
    Dwivedi, Ruti
    Ventura, Davide
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [39] Use of four-factor prothrombin complex concentrate in the reversal of warfarin-induced and nonvitamin K antagonist-related coagulopathy
    Young, Hannah
    Holzmacher, Jeremy L.
    Amdur, Richard
    Gondek, Stephen
    Sarani, Babak
    Schroeder, Mary E.
    BLOOD COAGULATION & FIBRINOLYSIS, 2017, 28 (07) : 564 - 569
  • [40] Four-Factor Prothrombin Complex Concentrate for the Reversal of Direct Oral Anticoagulants
    Zada, Ilanit
    Wang, Shan
    Akerman, Meredith
    Hanna, Adel
    JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (01) : 58 - 62
12345